Neal C. Bradsher
Director, 10% Owner · Lineage Cell Therapeutics, Inc.
Individual
- 2025
- Jul 2, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Neal C. Bradsher files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- BROADWOOD PARTNERS, L.P. - $62.75M in STAA purchases and sales in the last 12 months
- Brian M. Culley - $24K in LCTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Neal C. Bradsher?
Neal C. Bradsher is a corporate insider, tracked as Director, 10% Owner of Lineage Cell Therapeutics, Inc. (LCTX). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Neal C. Bradsher last file a Form 4?
The most recent primary Form 4 on record is dated 2 July 2026, one of 4 filings going back to 2025.
